Fact CheckerSign in

NCT04874909Completed

Classification, Functional Stratification and Biomarkers in Ciliopathy (CILLICORIRCM)

Classification and Functional Stratification of the Patients With Ciliopathy and Identification of Biomarkers to Improve Their Prognosis

Source: ClinicalTrials.gov · Last updated 6 May 2026

Brief summary (registry, in English)

The purpose of the C'IL-LICO RICM study is to develop innovative and transformative diagnostic and prognostic for patients suffering from ciliopathies leading to renal failure. The objectives is to decipher disease mechanisms and highlight signaling pathways altered in at-risk to develop renal failure patient groups and to produce a prognostic biomarker-based kit to predict the evolution of ciliopathy patients towards renal impairment.

Status (registry)
Completed
Study type
Interventional
Enrollment
240 (actual)
First submitted
31 Mar 2021
Start date
Nov 2021
Primary completion date
Oct 2024
Lead sponsor
Assistance Publique - Hôpitaux de Paris
NCT number
NCT04874909

What you commit to

  • Study type: Interventional
  • Participants enrolled: 240
  • From Nov 2021 to the primary completion date, Oct 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • use an experimental treatment during 30 days before inclusion date
    • Healthy related individual :
    • \- pregnant, parturious and nursing mothers.
    • "Negative Control" patient :
    • \- pregnant, parturious and nursing mothers.
    • "Positive Control" patient :
  • use an experimental treatment during 30 days before inclusion date

Other

  • pregnant, parturious and nursing mothers.
  • with functional renal graft
  • pregnant, parturious and nursing mothers.
  • with functional renal graft

Who the study is looking for

  • "Case" Patient :
  • with nephronophthisis or ciliopathy with known genetic diagnosis or not
  • signed the Informed consent form (patient or legal guardians if minor/incapable major)
  • no limit of age, this patients could be recruited from the birth
  • social insurance affiliation
    • Healthy related individual :
  • related with a included patient (father, mother, brother, sister)
  • signed the Informed consent form (major or legal guardians if minor/incapable major)
  • no limit of age, this patients could be recruited from the birth
  • social insurance affiliation
    • "Negative Control" patient :
  • without chronic renal failure
  • signed the Informed consent form (major or legal guardians if minor/incapable major)
  • no limit of age, this patients could be recruited from the birth
  • social insurance affiliation
    • "Positive Control" patient :
  • with chronic renal failure not related with a ciliary dysfunction
  • signed the Informed consent form (major or legal guardians if minor/incapable major)
  • no limit of age, this patients could be recruited from the birth
  • social insurance affiliation

Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Hopital Necker Enfants Malades
Coordinator of this site? Confirm its status
ParisFranceUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.